GlassScriptPhysician profile
Courtney Ryane Tyner
NPI 1356004717
$6,781.62
in general payments reported to CMS, 2019-2025
43 companies · $1,146 in 2025
The $1,146 reported for 2025 was more than what 85% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $265 · 2022: $1,988 · 2023: $2,020 · 2024: $1,362 · 2025: $1,146.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,529.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,528.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corcept Therapeutics | $856.15 | 2021-2024 | Korlym |
| Bayer Healthcare Pharmaceuticals INC. | $751.63 | 2022-2025 | |
| Xeris Pharmaceuticals, INC. | $540.60 | 2021-2024 | Gvoke Hypopen, Recorlev |
| Novo Nordisk INC | $432.14 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Dexcom, INC. | $408.62 | 2021-2025 | Dexcom G6 Transmitter, Dexcom G7 Gss (161) |
| Recordati_rare_diseases_inc. | $301.48 | 2021-2023 | Isturisa, Signifor Lar |
| Abbvie INC. | $282.01 | 2022-2025 | |
| Abbott Laboratories | $266.04 | 2023-2025 | Freestyle Libre 3, Proclaim |
| Sanofi-Aventis U.S. LLC | $240.91 | 2022-2024 | |
| Lilly USA, LLC | $236.02 | 2022-2025 | Jardiance, Mounjaro, Zepbound |
| Mannkind Corporation | $220.96 | 2022-2023 | Afrezza |
| Astrazeneca Pharmaceuticals LP | $219.40 | 2024-2025 | Airsupra |
| Pfizer INC. | $204.57 | 2025 | |
| Merck Sharp & Dohme LLC | $190.81 | 2022-2023 | Steglatro, Steglujan, Segluromet |
| Tandem Diabetes Care, INC. | $180.91 | 2022-2024 | T:Slim X2 Insulin Pump With Control-Iq |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $153.96 | 2024-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Eusa Pharma (US) LLC | $142.41 | 2022 | |
| Madrigal Pharmaceuticals | $141.87 | 2025 | Rezdiffra |
| Ibsa Pharma INC. | $133.78 | 2022-2024 | Tirosint, Licart, Licart |
| Esperion Therapeutics, INC. | $101.35 | 2021-2024 | Nexletol |
| Amarin Pharma, INC. | $90.66 | 2021-2023 | |
| Kyowa Kirin, INC. | $89.47 | 2022-2025 | Crysvita |
| Amgen INC. | $77.34 | 2024-2025 | Repatha, Krystexxa |
| Endo Pharmaceuticals INC. | $58.62 | 2021-2022 | |
| Cequr Corporation | $46.46 | 2022-2024 | Cequr Simplicity |
| Clarus Therapeutics INC. | $45.11 | 2021 | |
| Exact Sciences Corporation | $42.56 | 2025 | Cologuard Collection Kit |
| Medtronic, INC. | $35.95 | 2023-2024 | Minimed 780g |
| Antares Pharma, INC. | $31.27 | 2023-2024 | Xyosted, Nocdurna, Tlando |
| Novartis Pharmaceuticals Corporation | $30.33 | 2022 | |
| Lexicon Pharmaceuticals, INC. | $26.40 | 2024 | |
| Astellas Pharma US INC | $23.75 | 2023 | Veozah |
| Pacira Pharmaceuticals Incorporated | $22.38 | 2023 | Zilretta |
| Regeneron Healthcare Solutions, INC. | $20.70 | 2025 | Evkeeza |
| Zealand Pharma US, INC. | $20.20 | 2021 | |
| Chiesi USA, INC. | $17.72 | 2024 | Mycapssa |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.88 | 2024 | Jardiance |
| Ultragenyx Pharmaceutical INC. | $15.96 | 2023 | |
| Amryt Pharma Holdings LTD | $14.83 | 2022 | |
| Sumitomo Pharma America, INC. | $14.52 | 2025 | Gemtesa |
| Ascensia Diabetes Care US INC. | $13.73 | 2023 | |
| Currax Pharmaceuticals LLC | $13.23 | 2023 | Contrave, Onzetra Xsail |
| Beta Bionics, INC. | $7.93 | 2023 | Ilet Bionic Pancreas |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Courtney Tyner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.